Trial intelligence / Profile preview

Individually adapted 24-72 week peginterferon alfa-2b plus ribavirin therapy for chronic hepatitis C genotype 1

2006-000358-38Phase 4Completed

Sponsor

Goethe University Hospital Frankfurt Medical Clinic I

Start

Mar 2006

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1